麻醉症严重的药物使用模式:意大利的真实世界基于人口的队列研究
Marco Finocchietti1, Giada Crescioli2,3, Olga Paoletti4
1Department of Epidemiology, Lazio Regional Health Service, 00147 Rome, Italy.
Journal of clinical medicine
|June 19, 2024
概括
这项研究分析了2369名肌痛性骨髓灰质炎 (MG) 患者的药物使用情况,发现了多样化的治疗模式和需要结合疗法以更好地控制疾病. 对于MG的管理,新的治疗方法正在出现.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 骨髓灰质炎 (MG) 是一种罕见的神经肌肉疾病.
- 了解药物使用模式对于优化患者护理至关重要.
研究的目的:
- 评估一组MG患者的药物使用模式,包括pyridostigmine (Py) 和其他指示疗法.
- 为了评估主要疗法 (阿扎西奥普林,普雷迪尼松,维生素D) 的联合使用,按Py使用分层.
主要方法:
- 使用行政医疗保健数据进行回顾性队列研究.
- 包括2013年至2019年期间诊断的2369名MG患者.
- 在诊断后的第一年中,普遍和偶发性药物使用的评估.
主要成果:
- 38.4%的流行使用者和22.0%的偶发使用者使用了pyridostigmine (Py).
- 在Py流行 (74.5%) 和偶发 (82.0%) 用户中观察到高比例的普得尼松使用率.
- 在随访的第一年,Py使用者中使用组合疗法的增加.
结论:
- 目前的治疗模式表明,需要治疗方法,在MG中提供快速的症状缓解和持续的疾病控制.
- 新兴的治疗方法有望解决这些未满足的需求.
- 需要进一步的研究来评估MG的新疗法,并解决数据异质性.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
764
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
764
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Disorders of the Skeletal Muscle
928
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
928
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Direct-Acting Cholinergic Agonists: Therapeutic Uses
725
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
725


